Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclic dinucleotides as anticancer agents

Cyclic dinucleotides as anticancer agents

US Patent 11945834 · Granted Apr 2, 2024

Estimated economic value: $261,095,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alph2025
Substituted phenyl oxazolone compounds2025
Agonists of ROR GAMMAt2024
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2023
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2022
Cyclic dinucleotides as anticancer agents2021
Cyclic dinucleotides as anticancer agents2021
Cyclic dinucleotides as anticancer agents2021
Cyclic dinucleotides as anticancer agents2020